11. Vasconcelos C, Kallenberg C, Shoenfeld Y. (2011). Refractory disease in autoimmune diseases. Autoimmunity Reviews 10(11):653-4.
12. Wang LL, Jin YY, Hao YQ, Wang JJ, et al. (2011). Distribution and clinical features of primary immunodeficiency diseases in Chinese children (2004-2009). Journal of Clinical Immunology 31(3):297-308.
13. Wang LL, Jin YY, Hao YQ, Wang JJ, et al. (2011). Distribution and clinical features of primary immunodeficiency diseases in Chinese children (2004-2009). Journal of Clinical Immunology 31(3):297-308.
14. Vasconcelos C, Kallenberg C, Shoenfeld Y. (2011). Refractory disease in autoimmune diseases. Autoimmunity Reviews 10(11):653-4.
15. Wang LL, Jin YY, Hao YQ, Wang JJ, et al. (2011). Distribution and clinical features of primary immunodeficiency diseases in Chinese children (2004-2009). Journal of Clinical Immunology 31(3):297-308.
16. Wang LL, Jin YY, Hao YQ, Wang JJ, et al. (2011). Distribution and clinical features of primary immunodeficiency diseases in Chinese children (2004-2009). Journal of Clinical Immunology 31(3):297-308.
17. Otsubo K, Kanegane H, Kamachi Y, Kobayashi I, et al. (2011). Identification of FOXP3-negative regulatory T-like (CD4(+)CD25(+)CD127(low)) cells in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Clinical Immunology 141(1):111-20.
18. Girgis A, Stacey F, Lee T, Black D, et al. (2011). Priorities for women with lymphoedema after treatment for breast cancer: population based cohort study. BMJ: British Medical Journal 342:d3442.
19. Khan F, Pallant JF. (2011). Use of the International Classification of Functioning, Disability and Health to identify preliminary comprehensive and brief core sets for Guillain Barre syndrome. Disability and Rehabilitation 33(15-16):1306-13.
20. Khan F, Pallant JF. (2011). Use of the International Classification of Functioning, Disability and Health to identify preliminary comprehensive and brief core sets for Guillain Barre syndrome. Disability and Rehabilitation 33(15-16):1306-13.
21. Sogarwal R, Bachani D. (2011). Process evaluation of community care centers providing care, support, and treatment to people living with human immunodeficiency virus in India. Journal of Public Health Management and Practice 17(5):E18-23.
22. Korenromp IH, Heijnen CJ, Vogels OJ, van den Bosch JM, et al. (2011). Characterization of chronic fatigue in patients with sarcoidosis in clinical remission. Chest 140(2):441-7.
23. Jusufovic S, Hodzic E, Halilcevic A. (2011). Role of renal anemia in the functional, morphological and autoimmune thyroid disorders in patients on chronic hemodialysis. Medicinski Arhiv 65(4):228-32.
24. Straver DC, van den Berg LH, van Doorn PA, Franssen H. (2011). Symptoms of activity-induced weakness in peripheral nervous system disorders. Journal of the Peripheral Nervous System 16(2):108-12.
25. Stjernman H, Tysk C, Almer S, Strom M, et al. (2011). Unfavourable outcome for women in a study of health-related quality of life, social factors and work disability in Crohn's disease. European Journal of Gastroenterology and Hepatology 23(8):671-9.
26. Bassukas ID, Kosmidou M, Gaitanis G, Tsiouri G, et al. (2011). Patients with psoriasis are more likely to be treated for latent tuberculosis infection prior to biologics than patients with inflammatory bowel disease. Acta Dermato-Venereologica 91(4):444-6.
27. Khan F, Pallant JF. (2011). Use of the International Classification of Functioning, Disability and Health to identify preliminary comprehensive and brief core sets for Guillain Barre syndrome. Disability and Rehabilitation 33(15-16):1306-13.
28. Sogarwal R, Bachani D. (2011). Process evaluation of community care centers providing care, support, and treatment to people living with human immunodeficiency virus in India. Journal of Public Health Management and Practice 17(5):E18-23.
29. Bartalena L. (2011). The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy. Journal of Clinical Endocrinology and Metabolism 96(3):592-9.
30. Vogelgesang A, Dressel A. (2011). Immunological consequences of ischemic stroke: immunosuppression and autoimmunity. Journal of Neuroimmunology 231(1-2):105-10.
31. Pal J, Rozsa C, Komoly S, Illes Z. (2011). Clinical and biological heterogeneity of autoimmune myasthenia gravis. Journal of Neuroimmunology 231(1-2):43-54.
32. Wender M. (2011). Acute disseminated encephalomyelitis (ADEM). Journal of Neuroimmunology 231(1-2):92-9.
33. Findik S, Bulbul R, Ozbenli T, Aslan E, et al. (2011). Sarcoidosis and Gullain-Barre syndrome. Acta Neurologica Belgica 111(1):72-5.
34. Lockwood DN, Lambert SM. (2011). Human immunodeficiency virus and leprosy: an update. Dermatologic Clinics 29(1):125-8.
35. Dettmer M, Hegemann I, Hegemann SC. (2011). Extraintestinal Crohn's disease mimicking autoimmune inner ear disease: a histopathological approach. Audiology and Neuro-Otology 16(1):36-40.
36. Betterle C, Morlin L. (2011). Autoimmune Addison's disease. Endocrine Development 20:161-72.
37. Waqar S, Salman R, Sleep T. (2011). Ophthalmic manifestations of giant cell arteritis. British Journal of Hospital Medicine 72(1):26-30.
38. van Nes SI, Vanhoutte EK, van Doorn PA, Hermans M, et al. (2011). Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies. Neurology 76(4):337-45.
39. Spoerl D, Bircher AJ, Scherer K. (2011). Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom. Journal of Investigational Allergology and Clinical Immunology 21(1):22-7.
40. Punpanich W, Hays RD, Detels R, Chokephaibulkit K, et al. (2011). Development of a culturally appropriate health-related quality of life measure for human immunodeficiency virus-infected children in Thailand. Journal of Paediatrics and Child Health 47(1-2):27-33.
41. Tamagno G, Gaoatswe G. (2011). Time for the endocrinologists to expand their awareness of and contribution to the diagnosis and management of encephalopathy associated with autoimmune thyroid disease. Hormones 10(1):36-8.
42. Punpanich W, Hays RD, Detels R, Chokephaibulkit K, et al. (2011). Development of a culturally appropriate health-related quality of life measure for human immunodeficiency virus-infected children in Thailand. Journal of Paediatrics and Child Health 47(1-2):27-33.
43. Breda L, Del Torto M, De Sanctis S, Chiarelli F. (2011). Biologics in children's autoimmune disorders: efficacy and safety. European Journal of Pediatrics 170(2):157-67.
44. Daoud E, Chabchoub I, Neji H, Toumi N, et al. (2011). How MRI can contribute to the diagnosis of acute demyelinating encephalomyelitis in children. Neurosciences 16(2):137-45.
45. Schleich A, Baumann H. (2011). [Disease with generalized pain. Guillain-Barre syndrome]. Praxis 100(8):487-9.
46. Estcourt S, Quinn AG, Vaidya B. (2011). Quality of life in thyroid eye disease: impact of quality of care. European Journal of Endocrinology 164(5):649-55.
47. Xu X, Fu J, Fang Y, Liang L. (2011). Kimura disease in children: a case report and a summary of the literature in Chinese. Journal of Pediatric Hematology/Oncology 33(4):306-11.
48. Plazak W, Kopec G, Tomkiewicz-Pajak L, Rubis P, et al. (2011). Heart structure and function in patients with generalized autoimmune diseases: echocardiography with tissue Doppler study. Acta Cardiologica 66(2):159-65.
49. Strietzel FP, Lafaurie GI, Mendoza GR, Alajbeg I, et al. (2011). Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: a multicenter, randomized trial. Arthritis and Rheumatism 63(1):180-90.
50. Assie C, Janvresse A, Plissonnier D, Levesque H, et al. (2011). Long-term follow-up of upper and lower extremity vasculitis related to giant cell arteritis: a series of 36 patients. Medicine 90(1):40-51.
51. Maire F, Le Baleur Y, Rebours V, Vullierme MP, et al. (2011). Outcome of patients with type 1 or 2 autoimmune pancreatitis. American Journal of Gastroenterology 106(1):151-6.
52. Shacham R, Puterman MB, Ohana N, Nahlieli O. (2011). Endoscopic treatment of salivary glands affected by autoimmune diseases. Journal of Oral and Maxillofacial Surgery 69(2):476-81.
53. Heinze B, Swanepoel DW, Hofmeyr LM. (2011). Systematic review of vestibular disorders related to human immunodeficiency virus and acquired immunodeficiency syndrome. Journal of Laryngology and Otology 125(9):881-90.
54. Vasconcelos C, Kallenberg C, Shoenfeld Y. (2011). Refractory disease in autoimmune diseases. Autoimmunity Reviews 10(11):653-4.
55. Wang LL, Jin YY, Hao YQ, Wang JJ, et al. (2011). Distribution and clinical features of primary immunodeficiency diseases in Chinese children (2004-2009). Journal of Clinical Immunology 31(3):297-308.
56. Rozin AP, Egozi D, Ramon Y, Toledano K, et al. (2011). Large leg ulcers due to autoimmune diseases. Medical Science Monitor 17(1):CS1-7.
57. Goeldner I, Skare TL, de Messias Reason IT, Nisihara RM, et al. (2011). Autoantibodies for gastrointestinal organ-specific autoimmune diseases in rheumatoid arthritis patients and their relatives. Clinical Rheumatology 30(1):99-102.
58. Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, et al. (2011). Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. Journal of Hepatology 54(2):374-85.
59. Barabas AZ, Cole CD, Graeff RM, Lafreniere R, et al. (2011). The role of autoimmunologists in investigating and treating autoimmune disorders. Autoimmunity Reviews 10(3):166-70.
60. Bastuji-Garin S, Joly P, Lemordant P, Sparsa A, et al. (2011). Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. Journal of Investigative Dermatology 131(3):637-43.
